Table 3.
Functions of gut microbiota on Parkinson’s disease.
| Functions | Bacterial species | Functional substance | Mechanism of action | Ref. |
|---|---|---|---|---|
| Neurotransmitters secretion | Lactobacillus spp., Bifidobacterium spp. (Y2) Streptococcus salivarius subsp. thermophilus | GABA | GABA secretion, regulate neural signaling in the enteric nervous system, control the growth of hormone secretion, control brain function and behavior | (Barrett et al., 2012; Pokusaeva et al., 2017) |
| Escherichia spp., Saccharomyces spp. and Bacillus spp. | Noradrenaline | Noradrenaline secretion, regulate neural signaling in the enteric nervous system | (Shishov et al., 2009; Rogers et al., 2016) | |
| Streptococcus pp., Candida spp., Enterococcus spp. and Escherichia spp. | Serotonin | Serotonin secretion, regulate neural signaling in the enteric nervous system | (Özoğul, 2004; Shishov et al., 2009; Özoğul et al., 2012) | |
|
Bacillus spp., E. coli, Hafnia alvei, Proteus vulgaris, Serratia marcescens |
Dopamine | Convert l-tyrosine to L-DOPA, regulate neural signaling in the enteric nervous system | (Özoğul, 2004; Shishov et al., 2009; Rogers et al., 2016) | |
| Lactobacillus spp. | Acetylcholine | Acetylcholine secretion, induce epithelial cells to release molecules can regulate neural signaling in the enteric nervous system | (Reid, 2019; Rogers et al., 2016) | |
| Fermentation of dietary fiber | Prevotellaceae | Butyrate, acetate and propionate | Production of mucin and SCFAs, decreased SCFAs lead to increased intestinal permeability, exposure endotoxins, initiate excess α-syn expression and misfolding | (Sampson et al., 2016; Sarkar and Banerjee, 2019) |
| Rise serum lipopolysaccharide(LPS) | Enterobacteriaceae Gammaproteobacteria | LPS | Rise the serum LPS population, induce systemic inflammation, promotes α-synuclein deposition, increase LPS-α‐syn fibril formation | (Guo et al., 2013; Lin et al., 2019; Gorecki et al., 2019; Bhattacharyya et al., 2019) |
| Induce inflammatory responses | Ralstonia, Proteobacteria, Enteococcaceae | Pro-inflammatory cytokine | Increase of pro-inflammatory cytokine | (Keshavarzian et al., 2015) |
| Anti-inflammatory | Blautia, Coprococcus,and Roseburia and Faecalibacterium | Butyrate | The butyrate-producing bacteria such as Blautia, Coprococcus,Roseburia and Faecalibacterium decreased which have anti-inflammatory function | (Keshavarzian et al., 2015; Qiao et al., 2020) |
| Triggering factor in PD pathogenesis | Helicobacter pylori | Triggering factor in PD pathogenesis | (Keshavarzian et al., 2015; Çamcı and Oğuz, 2016) | |
| Worsening of motivation | Bacteroides fragilis,Bifidobacterium | Low counts of Bacteroides fragilis related with worsening of motivation/activeness and Bifidobacterium decreasing related with hallucinations/delusions | (Minato et al., 2017) | |
| Improve the bowel movement | Lactobacillus casei shirota | Improve the bowel movement, the number of fecal staphylococci was decreased | (Cassani et al., 2011) | |
| Increase bile acid | Ruminococcaceae Lactobacillus | CA and DCA | Have a role in cognitive decline | (MahmoudianDehkordi et al., 2019; O’Donovan et al., 2020); |
| Converting levodopa to dopamine | Enterococcus, Lactobacillus Staphylococcus | Tyrosine decraboxylase (TDC) | TDC in genome of bacterias, have the ability of converting levodopa to dopamine | (Zoetendal et al., 2012; van Kessel et al., 2019) |
| Neuroprotective effects |
B. animalis lactis, L. rhamnosus GG L. acidophilus |
Butyrate | Induce BDNF and glial cell line-derived neurotrophic factor (GDNF) upregulated | (Srivastav et al., 2019) |